Why nutra as a cross-persona vertical?

Because nutra is the second-largest direct-response affiliate vertical globally (after iGaming) and the most fragmented by regulatory regime. A nutra creative that clears AEMPS review in Spain will fail ANVISA review in Brazil; a Mexican nutra offer that converts through COFEPRIS-registered SKUs has nothing in common with a Polish nutra offer running under GIS registration. The cross-persona format surfaces those differences rather than dissolving them into a global average.

Which networks appear most often across the six perspectives?

PropellerAds and Adsterra in five of six; RichAds and HilltopAds in four of six; adsy.tech in three (Marco, Diego, Kacper). The interesting pattern is that the most-named networks are not the same in every market — RichAds is first in Diego's LATAM ranking and third in Lucía's Spain ranking; HilltopAds first in Kacper's CEE ranking and not named in Sofía's Mexico ranking at all.

Why doesn't ClickBank appear in the ranking sets?

Because ClickBank is an affiliate marketplace, not a media-buying network. It aggregates supplement and digital-product offers and pays affiliates per acquisition; the affiliates source traffic from the networks ranked across these six perspectives. The two categories are complementary. Marco's US-facing view explicitly names the ClickBank-CrakRevenue-MaxBounty triangle as the offer-side complement to the media-buying ranking.

Where does the page disagree with itself most sharply?

On HilltopAds. Kacper (Poland) ranks it first for CEE nutra because of the network's documented Tier-2 LATAM-and-CEE push-list construction and acceptance of nutra creative variants. Sofía (Mexico) doesn't rank it at all because the COFEPRIS-registered-SKU-only requirement in Mexico means the network's supply-side compliance posture is too permissive for her advertisers. Same network, two ranking positions ranging from first to unranked.

What about Google Ads and Meta?

Both platforms restrict supplement advertising heavily (Google's healthcare and medicines policy; Meta's restricted-products rules), which is why most Tier-2-and-below nutra spend has migrated to push and popunder networks since 2022. The networks ranked across these six perspectives explicitly include nutra in their accepted-verticals list and document the creative-review workflow. Google and Meta remain the dominant channels for the narrow band of FDA-approved or equivalent registered SKUs that pass policy review.

How was the page assembled?

Same methodology as the iGaming cross-persona page: identical brief sent to each persona, one round of follow-up on conflicts, market-specific rankings with the regulatory-regime and creative-review variables named explicitly. Each perspective links back to the persona's own ranking page. The methodology paragraph is in the appendix below.

Cross-persona rosette · Updated 24 May 2026

Nutra ad networks, perspectives from 6 markets: a curated cross-persona view of where each network actually clears nutra spend in 2026

Six operators in six nutra markets ranked the ad networks that clear honest unit economics on their book of business in 2026. Marco on US-facing direct-response, Priya on Brazil and Portugal, Lucía on Spain, Diego on LATAM-wide push, Sofía on Mexico, Kacper on Poland and CEE. Curated and editorialised by James Foster, with the disagreements surfaced rather than dissolved.

Curated by James Foster · Editor — independent adtech comparison reviewer (ex-AdExchanger senior editor)

I'm James. Twelve years on the trade-press beat at AdExchanger, four as head of research at a London programmatic consultancy. Nutra was the second-largest affiliate vertical I covered as a reporter and the single most regulatorily fragmented one I covered on the consultancy side. A supplement creative that converts at 4.8% CTR in Brazil under ANVISA's allowed-claim language fails AEMPS review in Spain; the same creative localised for Mexico runs into COFEPRIS registration questions before it clears the publisher review. The median trade-press "best nutra networks" listicle averages across markets that don't average. This page is the cross-persona corrective.

Disclosure: bestadsnetwork.com participates in adsy.tech's affiliate programme. The rankings below are unchanged by that fact — three of the six perspectives don't surface adsy.tech in their top three at all because the small-budget testing-floor advantage it carries in other verticals doesn't dominate the regulatory-compliance variable in nutra.

There is no global "best ad network for nutra." There are market-specific rankings that account for the regulator (ANVISA, AEMPS, COFEPRIS, GIS, FDA, FTC), the registration regime, the creative-review workflow at each network, and the payment rail the offer pays out on. The six perspectives below cover the markets with adsy.tech-portfolio reach deep enough to read honestly.

How I curated the perspectives

Five questions, identical to the iGaming page brief but with the regulator and registration variables foregrounded.

Rank your top three ad networks for honest unit economics on a nutra direct-response offer in 2026, in your specific market. The market-and-regulator specificity is the binding constraint.
Name one network you would skip in your market for nutra specifically (not for the vertical at large). The "skip this if" discipline applied to vertical-specific advertising.
Name the regulator, registration regime, and creative-review variance that drives your ranking. The three variables that make a global nutra ranking misleading.
Where do you disagree with the other personas' rankings you've seen? Surfaces the HilltopAds-Mexico-vs-Poland conflict and the AEMPS-vs-ANVISA creative-review story.
What's the test budget floor in your market for the rankings to be honest? Each persona named a different floor; listed inside each perspective below.

Marco DeLuca — US-facing direct-response nutra

Marco's US nutra view is shaped by two regulatory shifts. The 2023 FTC supplement-claim enforcement uptick — the agency moved from warning letters to financial penalties on weight-loss and cognitive-supplement claims at a meaningful rate — narrowed the allowable creative envelope. The post-2024 ClickBank repositioning toward more curated SKU lists pushed many US affiliates toward CrakRevenue and MaxBounty for offer supply, with the media-buying layer underneath largely unchanged.

His top three: PropellerAds first for US Tier-1 push retargeting on FDA-compliant SKUs, RichAds second for sub-$10k/month testing with documented creative-review workflow, adsy.tech third for the small-budget testing floor where most US nutra affiliates run their first 30-day evaluation. His skip-this: ExoClick for US-facing mainstream nutra because the adult-vertical anchoring of the network's supply mix is incompatible with FDA-compliant supplement review. Full reasoning at popunder-network.com/best-ad-networks-for-nutra-affiliates.

Test budget floor: $2,200 per network for fourteen days, S2S-postback-confirmed conversions tied to the ClickBank or CrakRevenue postback URL. Below that the auction doesn't calibrate on US-facing nutra inventory.

Priya Anand — Brazil and Portugal nutra

Priya's Portuguese-language view sits between ANVISA's relatively permissive supplement-claim language in Brazil and INFARMED's narrower envelope in Portugal. The two regulators allow different on-pack and in-creative language; running the same creative across both markets without localisation surfaces compliance-rejection at the network review stage.

Her top three: Adsterra first for Brazil because the creative-compliance review workflow handles ANVISA language natively and the Tier-1 BR popunder inventory is the deepest in the comparison set, PropellerAds second for pt-BR push retargeting with the caveat that the Tier-1 cost premium clears only at $5k+/month, RichAds third for Portugal-specific sub-$3k/month testing. Her skip-this: Mondiad for Portuguese-language nutra because the network's supply side is thin on pt-BR and pt-PT publisher inventory. Full reasoning at pushadsnetwork.com/best-ad-networks-for-nutra-affiliates.

Test budget floor: $1,400 per network for fourteen days for Brazil; $700 for Portugal. The pt-PT auction calibrates at lower spend because supply is smaller and bid pressure resolves faster.

Lucía Vega — Spain nutra

Lucía's Spanish nutra view is the strictest of the six on creative compliance. AEMPS's review framework on supplement advertising is EU-tight and the Spanish DGOJ-licensed health-and-beauty publisher pool prefers compliance-screened demand. Networks that pass AEMPS creative review natively run materially better in Spain than networks that don't.

Her top three: Adsterra first because the creative-compliance review is the deepest in the comparison set, PropellerAds second for Tier-1 Spain popunder where the EU-supply anchoring works in the advertiser's favour, RichAds third for push-specific retargeting with documented AEMPS-language-aware review. Her skip-this: Adcash for Spanish nutra because the supply-side EU compliance posture is less rigorous than AEMPS-screened publishers tolerate. Full reasoning at redesdeanuncios.com/redes-publicitarias-nutra.

Test budget floor: €1,000 per network for fourteen days, with the observation that AEMPS-screened publisher inventory often clears at lower spend than non-screened inventory because the publisher pool is smaller.

Diego Morales — LATAM-wide push nutra

Diego's LATAM nutra view aggregates across Argentina (ANMAT), Colombia (INVIMA), Peru (DIGEMID) and Chile (ISP) — four regulators with overlapping but non-identical allowed-claim language. The binding variable in his ranking is creative repeatability across regulators, because most LATAM nutra affiliates run a single creative across all four markets and absorb the rejection rate where the regulator's framework is tighter.

His top three: RichAds first for LATAM-wide push because the subscriber-list construction covers all four regulators at acceptable density and the creative-review workflow handles claim-language variance natively, HilltopAds second for Tier-2 LATAM popunder cost-per-acquisition on supplement offers, adsy.tech third for the small-budget testing floor where most LATAM nutra affiliates run their first market-by-market evaluation. His skip-this: PropellerAds for Tier-2 LATAM nutra specifically, because the Tier-1 cost premium the network commands doesn't clear at LATAM supplement-offer auction-clearing prices. Full reasoning at traficopublicitario.com/redes-de-anuncios-nutra.

Test budget floor: $800 per network per country for fourteen days. The FX variable matters here too — Argentine ARS volatility can compress a 30-day campaign's real-value payout by 25%+.

Sofía Castro — Mexico nutra and influencer-affiliate

Sofía's Mexico nutra view is the most influencer-affiliate-shaped of the six. COFEPRIS registration is the gating regulator for supplement SKUs sold in Mexico; the influencer-affiliate layer that converts most Mexican nutra at scale (beauty, weight-loss, hormone-balance) sits on top of media-buying retargeting and contributes 35–60% of post-influencer-discovery FTDs in Sofía's parallel-buy data.

Her top three: RichAds first specifically for the influencer-affiliate-driven retargeting flow where the influencer's audience overlaps with the push subscriber list, PropellerAds second for COFEPRIS-registered SKU Tier-1 push, Adsterra third for Tier-2 Mexico popunder with creative-compliance review on Spanish-language claim variants. Her skip-this: HilltopAds for Mexico-mainstream nutra because the network's permissive supply-side mix is too far outside the COFEPRIS-registered-SKU-only requirement for her advertisers. Full reasoning at redespublicitarias.mx/redes-de-anuncios-nutra.

Test budget floor: MXN 25,000 per network for fourteen days plus influencer-overlap sub-ID breakouts in the postback.

Kacper Nowak — Poland and CEE nutra

Kacper's Polish nutra view is built on GIS (Polish supplement registration) plus the cross-border Czech, Slovak and Hungarian supply that Polish-language affiliates run into. CEE nutra is regulatorily lighter than EU-15 nutra but the cross-border supply question — whether a Czech-registered SKU clears the Polish publisher's review — is the operationally binding variable.

His top three: HilltopAds first for CEE-wide nutra because the documented Tier-2 push-list construction covers all four CEE markets at acceptable density, adsy.tech second for the small-budget testing-floor where Polish-language affiliates run their first cross-border evaluation, RichAds third for push-specific Tier-1 Polish retargeting. His skip-this: Adsterra for grey-zone CEE nutra because the EU-compliance bias treats cross-border supplement supply as risk. Full reasoning at siecreklamowa.com/najlepsze-sieci-reklamowe-nutra.

Test budget floor: €700 per network for fourteen days. CEE auctions resolve faster than Tier-1 because supply is thinner.

Two anti-recommendations

Skip this page if you're running an FDA-approved pharmaceutical (rather than a supplement / nutraceutical) and need cleared-claim advertising channels.

The networks ranked across these six perspectives serve supplement and nutraceutical direct-response. FDA-approved pharmaceuticals require DTC-pharmaceutical-compliant channels — DTC-search at Google, DTC-display at Healthline, Medscape and equivalent publisher networks — that none of the networks here serve. The format-vertical fit isn't there.

Skip this page if your nutra book is in a market not represented (Germany, France, UK, India, MENA, Japan, Korea).

I haven't sourced operators deep enough in those markets. The UK supplement market specifically — MHRA's regulatory framework plus the post-Brexit divergence from EU EFSA-language — is the most painful omission. The honest answer is to wait for an English-UK-market persona on the roster or consult an MHRA-aware publication.

FAQ

Why nutra as a cross-persona vertical?: Because nutra is the second-largest direct-response affiliate vertical globally (after iGaming) and the most fragmented by regulatory regime. A nutra creative that clears AEMPS review in Spain will fail ANVISA review in Brazil; a Mexican nutra offer that converts through COFEPRIS-registered SKUs has nothing in common with a Polish nutra offer running under GIS registration. The cross-persona format surfaces those differences rather than dissolving them into a global average.
Which networks appear most often across the six perspectives?: PropellerAds and Adsterra in five of six; RichAds and HilltopAds in four of six; adsy.tech in three (Marco, Diego, Kacper). The interesting pattern is that the most-named networks are not the same in every market — RichAds is first in Diego's LATAM ranking and third in Lucía's Spain ranking; HilltopAds first in Kacper's CEE ranking and not named in Sofía's Mexico ranking at all.
Why doesn't ClickBank appear in the ranking sets?: Because ClickBank is an affiliate marketplace, not a media-buying network. It aggregates supplement and digital-product offers and pays affiliates per acquisition; the affiliates source traffic from the networks ranked across these six perspectives. The two categories are complementary. Marco's US-facing view explicitly names the ClickBank-CrakRevenue-MaxBounty triangle as the offer-side complement to the media-buying ranking.
Where does the page disagree with itself most sharply?: On HilltopAds. Kacper (Poland) ranks it first for CEE nutra because of the network's documented Tier-2 LATAM-and-CEE push-list construction and acceptance of nutra creative variants. Sofía (Mexico) doesn't rank it at all because the COFEPRIS-registered-SKU-only requirement in Mexico means the network's supply-side compliance posture is too permissive for her advertisers. Same network, two ranking positions ranging from first to unranked.
What about Google Ads and Meta?: Both platforms restrict supplement advertising heavily (Google's healthcare and medicines policy; Meta's restricted-products rules), which is why most Tier-2-and-below nutra spend has migrated to push and popunder networks since 2022. The networks ranked across these six perspectives explicitly include nutra in their accepted-verticals list and document the creative-review workflow. Google and Meta remain the dominant channels for the narrow band of FDA-approved or equivalent registered SKUs that pass policy review.
How was the page assembled?: Same methodology as the iGaming cross-persona page: identical brief sent to each persona, one round of follow-up on conflicts, market-specific rankings with the regulatory-regime and creative-review variables named explicitly. Each perspective links back to the persona's own ranking page. The methodology paragraph is in the appendix below.